Highbridge Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-17,180
Closed -$594K 774
2018
Q2
$594K Sell
17,180
-351,720
-95% -$12M 0.01% 558
2018
Q1
$12.4M Buy
368,900
+361,417
+4,830% +$12.4M 0.2% 113
2017
Q4
$258K Sell
7,483
-1,060,746
-99% -$36.2M ﹤0.01% 1327
2017
Q3
$36.2M Buy
+1,068,229
New +$34.3M 0.54% 33
2017
Q2
Sell
-831,079
Closed -$27M 1520
2017
Q1
$27M Buy
831,079
+794,927
+2,199% +$25.1M 0.39% 57
2016
Q4
$1.11M Buy
36,152
+2,635
+8% +$80.4K 0.02% 520
2016
Q3
$1.08M Sell
33,517
-65,664
-66% -$2.2M 0.02% 546
2016
Q2
$3.31M Buy
+99,181
New +$3.17M 0.05% 335
2015
Q3
Sell
-109,300
Closed -$3.48M 1760
2015
Q2
$3.48M Sell
109,300
-47,746
-30% -$1.56M 0.04% 377
2015
Q1
$5.18M Buy
157,046
+146,717
+1,420% +$4.66M 0.07% 296
2014
Q4
$304K Sell
10,329
-55,335
-84% -$1.59M ﹤0.01% 961
2014
Q3
$1.84M Sell
65,664
-738
-1% -$20.7K 0.02% 506
2014
Q2
$1.87M Sell
66,402
-21,607
-25% -$616K 0.02% 436
2014
Q1
$2.68M Buy
88,009
+18,129
+26% +$541K 0.03% 346
2013
Q4
$2.03M Buy
69,880
+41,422
+146% +$1.21M 0.02% 396
2013
Q3
$776K Buy
28,458
+10,856
+62% +$295K 0.01% 743
2013
Q2
$469K Buy
+17,602
New +$486K ﹤0.01% 905

Other funds holding PFE

Highbridge Capital Management's PFE Position: Q4 2018 in Review

Highbridge Capital Management sold out of Pfizer (PFE) in Q4 2018, closing a stake of 223,057 shares — an estimated $9.33M sold.

Highbridge Capital Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $58M in Q2 2014. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Highbridge Capital Management reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 223,057 Pfizer shares in Q4 2018, an estimated $9.33M.
  • Highbridge Capital Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
  • Highbridge Capital Management's Pfizer position peaked at $58M in Q2 2014.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.